Stanislav Yurievich Usenkov

Stanislav Yurievich Usenkov

Auto-generated profile, based on publicly available information

Stanislav Yurievich Usenkov

Research Institute of Cardiology, Tomsk National Research Medical Centre of the Russian Academy of Sciences

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2022 in Kardiologiia
Verified
Journal Article
Closed access
PDF file
OEO. R. Eshmatov
O. R. Eshmatov
RBR. E. Batalov
R. E. Batalov
EAEvgenii A. Archakov
Evgenii A. Archakov
SUS. Yu. Usenkov
S. Yu. Usenkov
SPSergey Popov
Sergey Popov
Aim To evaluate efficacy and safety of the anticoagulant therapy in patients with atrial fibrillation (AF) during a 36-month follow-up after an interventional treatment. Material and methods This study included 302 patients aged 29 to 81 years with various forms of AF. Catheter ablation (CA) of AF foci was performed for all patients. The patients were divided into 3 groups: group 1 with paroxysmal AF, group 2 with persistent AF, and group 3 with longstanding persistent AF. Two subgroups were isolated in each group, with effective and ineffective CA. Results of the follow-up were analyzed at 12, 24, and 36 months after discharge from the hospital. The follow-up interview recorded complaints of palpitation attacks, effectiveness of administered CA, compliance with the treatment, adverse clinical outcomes, including thromboembolic complications (TEC), bleeding, and hospitalizations. Results Efficacy of the interventional treatment for 36 months was 65.3 % in patients with paroxysmal AF, 59.7 % in patients with persistent AF, and 57.1 % in patients with longstanding persistent AF. Patients with paroxysmal AF and effective CA had no adverse events throughout the same period during the antithrombotic treatment (ATT). In contrast, the group with ineffective ablation had both TEC and hemorrhagic complications during the ATT. In the group with persistent AF and effective CA throughout the follow-up period, TECs were less frequent than in the group of ineffective ablations during the ATT treatment. Patients with longstanding persistent AF and effective CA throughout the follow-up period, had no TECs in contrast to patients with ineffective ablation during the ATT treatment. There were no fatal outcomes in patients with effective procedure. Conclusion A successful CA procedure for AF provides a significant decrease in the risk of ischemic stroke. Furthermore, the invasive strategy does not increase the risk of major and minor bleedings.

7 February 2025 in Journal of Arrhythmology
Verified
Journal Article
Open access
PDF file
LKL. E. Korobchenko
L. E. Korobchenko
TLT. A. Lyubimtseva
T. A. Lyubimtseva
KDKarapet Davtyan
Karapet Davtyan
ATA. G. Topchyan
A. G. Topchyan
GSG. Yu. Simonyan
G. Yu. Simonyan
ГСГ. Ю. Симонян
Г. Ю. Симонян
Aim. To study the characteristics of the atrial fibrillation (AF) cryoballoon ablation (CBA) procedure and features of patient’s management in real clinical practice in Russia.Methods. “Prospective Atrial Fibrillation Cryoablation Registry” is an observational prospective national multicenter study. It was conducted from 01.2017 to 12.2019 in centers of Russian Federation. The registry included patients over the age of 18 who were agreed to participate this study and had indications for CBA of AF. The study protocol did not provide for significant restrictions on inclusion criteria, procedure technique and postoperative follow-up. The data was collected prior to the CBA of AF, during hospitalization for CBA and on the 12-month follow-up.Results. Participating centers enroll 980 patients according to inclusion criteria. CBA of AF was performed in 976 (99.6%) (mean age 59.7±9.2 years, 545 (55.8%) men) primary procedure - 840 (86.1%), re-ablation - 136 (13.9%). Parox- ysmal AF occurred in 828 (84.8%) patients and persistent AF (mean time of persistence 4.4±3.7 months) - in 145 (15.1%) patients. The average procedure time was 108.1±33.3 minutes and mean fluoroscopy time was 24.9±13.6 min. Most of the procedures were performed under general anesthesia. Complications after AF CBA occurred in 53 (5.4%) patients. The most common complication was paresis of the phrenic nerve - 20 (37.7%) cases which were associated with lower temperatures of CBA application of the right pulmonary veins (τ=0.08; p<0.05). The features of antiarrhythmic and anticoagulant therapy were evaluated. A group of patients without adequate anticoagulant therapy in the postoperative period was identified. Due to COVID-19 restrictions only 374 (38.3%) patients completed 12-month follow-up. The recurrence of arrhythmia was occurred in 85 (22.7%) patients. Multivariate regression analysis revealed the following predictors of arrhythmia recurrence: the first procedure (OR 3.96; p=0.023), male sex (OR 1.77; p=0.014), duration of the procedure (min) (OR 1.01; p=0.007).Conclusion. CBA is an effective and relatively safe procedure for the treatment of paroxysmal and persistent AF. Data from real clinical practice show a low proportion of serious complications of AF CBA. Data on the dynamics of drug therapy, including anticoagulant and antiarrhythmic therapy, were obtained. The attention of specialists performing AF catheter ablation and patient monitoring is required, since errors in patient management have been identified.

7 October 2021 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
EAEvgenii A. Archakov
Evgenii A. Archakov
RBR. E. Batalov
R. E. Batalov
SUS. Y. Usenkov
S. Y. Usenkov
SPSergey Popov
Sergey Popov
The article describes clinical cases demonstrating the advantages of non-invasive long-term electrocardiogram (ECG) monitoring allowing to detect asymptomatic atrial fibrillation (AF) and transient atrioventricular (AV) and sinoatrial (SA) blocks.

8 August 2022 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
TMT. V. Moskovskikh
T. V. Moskovskikh
ASA. V. Smorgon
A. V. Smorgon
EAE. V. Archakov
E. V. Archakov
SUS. Yu. Usenkov
S. Yu. Usenkov
RBR. E. Batalov
R. E. Batalov
SPSergey Popov
Sergey Popov
Aim. To evaluate the effect of catheter ablation on left (LA) and right atria (RA) function in patients with atrial fibrillation.Material and methods. The study included 28 patients (14 men and 14 women) aged 33 to 72 years (mean age, 57,7±9,9 years) with paroxysmal (n=23) and persistent AF (n=5). All patients underwent radiofrequency ablation (RFA) with pulmonary vein antrum isolation. Before ablation and 3 days after, transthoracic twodimensional echocardiography was performed in sinus rhythm with an assessment of LA reservoir, conduit and booster pump function and RA peak longitudinal strain.Results. In the studied patients, a significant decrease in the reservoir, conduit and booster pump function of the LA was revealed after RFA, while there was no significant change in RA peak longitudinal strain after catheter ablation. LA reservoir, conduit and booster pump function decreased by 6,45% (p<0,001), 3,59% (p<0,001), 2,85% (p<0,001), respectively, while RA peak longitudinal strain increased by 0,73% (p=0,43).Conclusion. Catheter ablation has a significant damaging effect on the LA tissue, inhibiting the reservoir, pumping and pipeline functions. At the same time, the contractility of the PP in the early postoperative period improves, but not significantly.

4 December 2024 in Journal of Arrhythmology
Verified
Journal Article
Open access
PDF file
TMT. V. Moskovskih
T. V. Moskovskih
ASA. V. Smorgon
A. V. Smorgon
SUS. Yu. Usenkov
S. Yu. Usenkov
EAEvgenii A. Archakov
Evgenii A. Archakov
ESE. S. Sitkova
E. S. Sitkova
SSSvetlana Ivanovna Sazonova
Svetlana Ivanovna Sazonova
Aim. Search for predictors of early recurrence of atrial tachyarrhythmias after radiofrequency ablation (RFA) of atrial fibrillation (AF).Methods. The study included 57 subjects with persistent (n = 17; 30%) and paroxysmal (n = 40; 70%) forms of AF, admitted for the RFA. All patients underwent transthoracic echocardiography, assessment of deformation of both atria using 2D Strain, computed tomography (CT) with 3D reconstruction of the left atrium (LA). Intraoperatively, high-density voltage mapping of LA was performed before RF pulmonary vein isolation. All patients underwent follow-up after 3 months.Results. Recurrence of atrial tachyarrhythmia after 3 months was recorded in 17.5% of patients. High prevalence of low-amplitude activity zones in the LA and persistent AF were the strongest predictors. The LA reservoir function below 21.7%, the conduction function below 15.7%, the LA stiffness index above 0.314 relative units, the LA volume with the appendage above 121.7 ml, and the LA vertical size according to CT data above 65.5 mm statistically significantly predicted early recurrences of atrial tachyarrhythmias with high sensitivity and specificity.Conclusion. The decreased LA deformation in the reservoir and conductor phase, increased LA stiffness index, the prevalence of low-amplitude activity zones, vertical size and volume of the LA with an auricle according to CT data and persistent AF are significant predictors of early relapses after interventional treatment of AF.

5 October 2025 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
AGAnna Gusakova
Anna Gusakova
TSTatiana E. Suslova
Tatiana E. Suslova
EAEvgenii A. Archakov
Evgenii A. Archakov
SUS. Yu. Usenkov
S. Yu. Usenkov
RBR. E. Batalov
R. E. Batalov
Introduction. Oxidative stress holds a prominent position among the complex and multifactorial pathological mechanisms of atrial fibrillation (AF). It induces structural changes in the atria, promotes myocardial remodeling and arrhythmia progression, and is associated with recurrences after interventional treatment. Currently, there is a lack of data regarding the relationship between plasma levels of oxidative stress biomarkers and the clinical efficacy of catheter ablation for AF in patients with cardiac arrhythmias.Aim: To assess levels of laboratory biomarkers of prooxidant and antioxidant status in the blood plasma of patients with AF and their relationship with the effectiveness of interventional treatment.Material and Methods. The study included 39 patients with idiopathic AF hospitalized for interventional treatment by radiofrequency ablation (RFA) of the pulmonary vein ostia. Quantitative determination of biomarkers in the blood was performed by enzyme-linked immunosorbent assay (ELISA) before the surgery. Data on AF relapses and the time of their onset were collected and analyzed for 3 months.Results. The patients were divided into groups: 1st gr. – paroxysmal AF, 2d gr. persistent, 3d gr. long-term persistent. In all groups, the PerOx level corresponded to a high degree of oxidative stress. In 1st gr. and 3d gr., the relationships between PerOx and the CRP level are shown. An increase in the duration of the disease period was associated with a decrease in the concentration of Gpx1 in the 1st gr. For 2d gr., the relationship of PerOx with the age of patients is shown. The effectiveness of RFA did not differ significantly between the groups and amounted to 78,6, 75 and 84,6%, respectively. The relationships of biomarkers with the development of arrhythmia recurrence after RFA are shown. In 1st gr., in patients with episodes of arrhythmia, the PerOx level was higher compared to other forms of AF.Conclusion. Measuring biomarkers reflecting systemic oxidative stress and antioxidant status in patients with AF is a promising tool for monitoring and evaluating the effectiveness of interventional arrhythmia treatment.